Ozempic commonly causes nausea, fullness, and appetite suppression, but similar symptoms can also occur with gastroparesis. Learn the warning signs that help distinguish routine digestive side effects from a potentially serious gastric emptying disorder.
Rapid weight loss is often viewed as proof that GLP-1 medications are working. But in some cases, worsening nausea, extreme fullness, and food intolerance may signal gastroparesis rather than successful appetite control.
GLP-1 medications such as Ozempic and Wegovy intentionally slow digestion, but in rare cases this effect can progress to gastroparesis. Learn how to recognize warning signs, understand risk factors, and know when medical evaluation is necessary.
Exenatide helped define the modern GLP-1 era long before Ozempic became mainstream. This evidence-based review explains how exenatide worked, why Bydureon and Byetta were discontinued, and why stopping GLP-1 therapy often leads to rebound weight gain without a structured maintenance plan.
Type 2 diabetes treatment has changed rapidly in the past few years, largely because of GLP-1 receptor agonists. These medications do more than lower blood sugar. They also affect appetite, digestion, cardiovascular risk, and body weight. Two of the most widely discussed options are Trulicity and Ozempic. Both are once-weekly injectable medications approved for adults … Read more